Lerner Neil
Compass Therapeutics, Inc. · Chief Accounting Officer
Lerner Neil is listed in filings as Chief Accounting Officer at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 30, 2026, including purchase activity. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX). The current snapshot covers public activity from Feb 13, 2025 to Apr 30, 2026. Reported amounts are shown as $28.4K to $323.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $28k15k shares | BuyApr 29, 2026 | $1.89 | $2.11 |